TrialNature communications2026

Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial.

Valentina O Puntmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.